Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
10/2003
10/15/2003EP1259508B1 Novel biarylcarboxamides
10/15/2003EP1244427B1 Pharmaceutical compositions for oral administration
10/15/2003EP1183037B1 Compositions for modulating immune response and for the treatment of inflammatory disease
10/15/2003EP0950047B1 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them
10/15/2003EP0876140B1 Improved kontrast agent solutions for intravenous administration
10/15/2003CN1449448A 干细胞分化 Stem cell differentiation
10/15/2003CN1449386A Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
10/15/2003CN1449291A Novel specific mechanism for inhibiting adherence of platelets to collagen
10/15/2003CN1448172A Folium ginkgo injection and preparation thereof
10/15/2003CN1448145A Bicarbonate dry powder composition for hemodialysis
10/15/2003CN1124348C Multi-functional hematopoietic receptor agonists
10/15/2003CN1124283C Peptide, bronchodilator and blood flow ameliorant
10/14/2003US6632962 Caspase inhibitors and uses thereof
10/14/2003US6632945 Treating inflammation, autoimmune diseases, destructive bone disorders, proliferative disorders, infections, neurvous system disorders, reperfusion/ischemia in stroke, cardiovascular disorders, hypoxia, edema, fever, pain
10/14/2003US6632920 Immunology; diagnosing cancer, nervous system, brain, sleep, psychological, and disorders
10/14/2003US6632836 To treat autoimmune disorders, cardiac arrhythmias and the like
10/14/2003US6632791 Thrombomodulin analogs for pharmaceutical use
10/14/2003US6632428 Hyperlipidemia, lowering both the serum cholesterol and serum triglyceride levels, culturing a Lovastatin-producing Monascus strain
10/14/2003US6632426 G-CSF analog compositions and methods
10/14/2003CA2165828C Peptidase resistant thrombin receptor peptide ligand
10/14/2003CA2074820C Improved cyclodextrin based erythropoietin formulation
10/09/2003WO2003083135A2 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2)
10/09/2003WO2003083039A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/09/2003WO2003082869A1 Azaindoles as inhibitors of c-jun n-terminal kinases
10/09/2003WO2003082868A1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
10/09/2003WO2003082847A1 Benzofuran derivative
10/09/2003WO2003082829A1 New aryl imidazoles and related compounds as c5a receptor modulators
10/09/2003WO2003082827A1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents
10/09/2003WO2003082807A2 Amino acids with affinity for the alpha-2-delta-protein
10/09/2003WO2003082787A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003WO2003082338A1 Remedies for glomerular diseases
10/09/2003WO2003082314A2 Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1)
10/09/2003WO2003082279A1 Solid preparation containing single crystal form
10/09/2003WO2003082271A2 Indole derivatives having anti-angiogenetic activity
10/09/2003WO2003082264A1 Pharmaceutical composition for preventing or treating respiratory disease
10/09/2003WO2003082245A1 Methods of using lamellar bodies for therapeutic purposes
10/09/2003WO2003082197A2 Immunosuppressant compounds, methods and uses related thereto
10/09/2003WO2003047620A3 Compositions and methods for producing vascular occlusion
10/09/2003WO2003045328A3 Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof
10/09/2003WO2003041634A3 Bag system for cryopreservation of body fluids
10/09/2003WO2003016341A3 Regulation of iron uptake
10/09/2003WO2002092004A3 Use of hmg fragment as anti-inflammatory agents
10/09/2003WO2002083627A3 Ligands des integrins avss6
10/09/2003WO2002077017A3 Medical uses of intercellular communication facilitating compounds
10/09/2003WO2002033099A3 Human kinases
10/09/2003WO2002030433A3 Use of stem cells and cd6-depleted stem cells for inducing tolerance of allogenic transplants and/or for treating leukaemia
10/09/2003WO2002017953A3 Thrombomodulin analogs for use in recovery of signal cord injury
10/09/2003WO2001085917A3 A device
10/09/2003US20030191291 Synthetic erythropoiesis stimulating proteins
10/09/2003US20030191278 Of given amino acid sequence; use as thrombolytic drugs and vasodilators
10/09/2003US20030191175 Indole sPLA2 inhibitors
10/09/2003US20030191170 Central nervous system disorders; antiallergens; respiratory system disorders
10/09/2003US20030191155 Triazole derivatives
10/09/2003US20030191153 Antithrombotic amides
10/09/2003US20030191139 Anticoagulant for mammals
10/09/2003US20030191122 Antidepressants; Alzheimer's disease; Parkinson's disease; central nervous system disorders
10/09/2003US20030191098 Synergistic mixture of thalidomide antiinflammatory agnets
10/09/2003US20030191090 Anemia therapy; hydrogenation dextrin; reacting with ferric salt; complexing
10/09/2003US20030191074 Antibody therapy; immobilization
10/09/2003US20030191056 Immobilization onto polyoxyethylene glycol
10/09/2003US20030191050 Method and apparatus for preparing an acellular read blood cell substitute
10/09/2003US20030190687 Interacts with human DR5 to produce agonistic or antagonistic effects including inhibition of cell proliferation and apoptosis; used to treat apoptosis-related disease and unregulated cell growth
10/09/2003US20030190642 Thymus expressed human cytochrome p450(p450tec)
10/09/2003US20030190613 Polynucleotide encoding an activated human T-lymphocyte-derived protein related to ubiquitin conjugating enzyme
10/09/2003US20030190342 Administering to the vascular tissue a therapeutically effective amount of Saratin polypeptide to prevent platelet adhesion, so inhibiting thrombosis and restenosis
10/09/2003CA2480888A1 New aryl imidazoles and related compounds as c5a receptor modulators
10/09/2003CA2480317A1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
10/09/2003CA2480054A1 Pharmaceutical composition for preventing or treating respiratory disease
10/09/2003CA2479939A1 Immunosuppressant compounds, methods and uses related thereto
10/09/2003CA2479205A1 Azaindoles as inhibitors of c-jun n-terminal kinases
10/09/2003CA2478017A1 Therapeutic agent for glomerular disease
10/09/2003CA2477764A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003CA2448540A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/08/2003EP1350520A1 Human transferrin for treatment of anaemia of chronic disease (ACD) and functional iron deficiency
10/08/2003EP1350511A1 Medicinal compositions containing aspirin
10/08/2003EP1349930A2 Human proteins, polynucleotides encoding them and methods of using the same
10/08/2003EP1349924A2 Methods and compositions for the diagnosis of cancer susceptibilites and defective dna repair mechanisms and treatment thereof
10/08/2003EP1349919A1 Extramedullary adipose tissue cells and use thereof for regenerating hematopoietic and muscular tissues
10/08/2003EP1349918A1 Method of collecting placental stem cells
10/08/2003EP1349847A1 Oxybenzamides derivatives as factor xa inhibitors
10/08/2003EP1349840A2 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
10/08/2003EP1349835A2 (+)-1-(3,4-dichlorophenyl)-3-azabicyclo 3.1.0]hexane, compositions and uses thereof
10/08/2003EP1349832A2 Substituted benzoindoles as spla2 inhibitors
10/08/2003EP1349613A2 Thrombopoietin mimetics
10/08/2003EP1349589A1 A device and a method for dispensing at least two mutually reactive components
10/08/2003EP1123304B1 Flavonoids derived from citrus peels as collagen-induced platelet aggregation inhibitor
10/08/2003EP0946512B1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
10/08/2003EP0750628B1 Fibroblast growth factor-10
10/08/2003EP0670898B1 Interleukin-3 (il-3) mutant polypeptides
10/08/2003EP0650364B1 Purification of factor ix
10/08/2003CN1447820A Heparin-derived polysaccharide mixtures, prepn. method and pharmaceutical compsns. contg. same
10/08/2003CN1447818A Anti-heparin peptides
10/08/2003CN1447811A Medicinal compsns. and its use
10/08/2003CN1447799A Giphenyl derivatives and use thereof as integrin inhibitors
10/08/2003CN1447795A Biphenyl derivatives and use thereof as integrin inhibitors
10/08/2003CN1447699A Peptide and peptide minetic conjugates with integrin-inhibitor properties
10/08/2003CN1123639C Human activated protein C and its prepn. process
10/08/2003CN1123574C Ligands for FLT3 receptors
10/08/2003CN1123342C Use of inhibitors of renin-angiotension system
10/07/2003US6630505 Aminopyrrolidine sulfonamides as serine protease inhibitors
1 ... 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 ... 671